Current Funding:
MPI, Improving Social Connectedness through Digital Health to Enhance Recovery from OUD among the Justice Involved Population, NIDA, Grant#1R34DA058299, 6/15/2023-4/30/2026
Director, Rhode Island Hospital Injury Control Center for Biomedical Research Excellence (COBRE) – Digital Health Innovation Core, NIGMS, Grant#1P20GM139664, 4/1/2022 – 1/21/2027.
Co-I, Identifying optimal buprenorphine dosing for OUD treatment and prevention of overdose, NIDA, Grant#1UG3DA056880, 7/1/2022 - 6/30/2027.
MPI, Integrating Long-Acting Injectable Treatment to Improve Medication Adherence among Persons Living with HIV and Opioid Use Disorder. NIDA, Grant#R34DA055498, 04/01/2022-02/28/2025.
Co-I, Increasing peer support for OUD recovery during COVID-19 through digital health: A national randomized controlled trial. NIDA, Grant#R01DA054698, 8/1/2021-07/31/2026.
Co-I, A Randomized Controlled Trial to Evaluate a Trauma-Informed Partner Violence Intervention Program. PCORI. 10/01/2024-9/30/2029.
Co-I, Development and Evaluation of a Mobile Health Intervention for Co-Morbid Opioid Use Disorder and Posttraumatic Stress Disorder During Community Re-entry. NIDA, Grant#1R61DA061335-01, 9/15/2024 – 8/31/2026.
Co-I, A Randomized Trial of Chatbot for Prenatal Genetic Counseling, Grant#1R01HD111426-01A1, NICHD, 9/18/2024 - 8/31/2029.
Co-I, Diagnostic decision support systems for patients in urgent primary care or with stroke: evaluation of safety, usability and effectiveness for diagnosis, triage and patient decision making, Grant#5R01HS029513, AHRQ, 7/01/2023-5/31/2028.